AGIANA PHARMACEUTICALS AS
0349 OSLO
Return on Equity
101,02Â %
Current Ratio
9,83
Debt-to-Equity Ratio
−2,3
| Key figures (NOK) | 2022 | |
|---|---|---|
| Revenue | 0 | |
| Net Income | −2 959 000 | |
| Total Assets | 4Â 226Â 000 | |
| Total Equity | −2 929 000 |
| Income (NOK) | 2022 | |
|---|---|---|
| Revenue | 0 | |
| Expenditure | 2Â 846Â 000 | |
| Operating Profit | −2 846 000 | |
| Financial Income | 6Â 000 | |
| Financial Costs | 119Â 000 | |
| Financial Balance | −113 000 | |
| Earnings Before Tax | −2 959 000 | |
| Tax | 0 | |
| Net Income | −2 959 000 |
| Balance (NOK) | 2022 | |
|---|---|---|
| Total Fixed Assets | 0 | |
| Total Current Assets | 4Â 226Â 000 | |
| Total Assets | 4Â 226Â 000 | |
| Total Retained Equity | −2 959 000 | |
| Total Equity | −2 929 000 | |
| Total Long-Term Debt | 6Â 726Â 000 | |
| Total Current Debt | 430Â 000 | |
| Total Equity and Debt | 4Â 226Â 000 |
| Cash flow (NOK) | 2022 | |
|---|---|---|
| Sales Income | 0 | |
| Other Income | 0 | |
| Revenue | 0 | |
| Cost of Goods Sold | 0 | |
| Salary Costs | 1Â 279Â 000 | |
| Depreciation | 0 | |
| Impairment | 0 | |
| Expenditure | 2Â 846Â 000 | |
| Operating Profit | −2 846 000 | |
| Financial Income | 6Â 000 | |
| Financial Costs | 119Â 000 | |
| Financial Balance | −113 000 | |
| Dividends | 0 | |
| Net Income | −2 959 000 |
| Balance details (NOK) | 2022 | |
|---|---|---|
| Goodwill | 0 | |
| Total Intangible Assets | 0 | |
| Real Eastate | 0 | |
| Machinery and Plant Facilities | 0 | |
| Fixtures | 0 | |
| Total Tangible Assets | 0 | |
| Total Fiancial Fixed Assets | 0 | |
| Total Fixed Assets | 0 | |
| Stock | 0 | |
| Total Investments | 0 | |
| Cash, Bank | 4Â 000Â 000 | |
| Total Current Assets | 4Â 226Â 000 | |
| Total Assets | 4Â 226Â 000 | |
| Total Equity | −2 929 000 | |
| Short-Term Group Debt | 0 | |
| Total Long-Term Debt | 6Â 726Â 000 | |
| Creditors | 60Â 000 | |
| Unpaid Taxes | 143Â 000 | |
| Dividends | 0 | |
| Other Current Debt | 226Â 000 | |
| Total Current Debt | 430Â 000 | |
| Total Equity and Debt | 4Â 226Â 000 |
| Financial indicators | 2022 | |
|---|---|---|
| Return on Equity | 101,02Â % | |
| Debt-to-Equity Ratio | −2,3 | |
| Operating Profit Margin | - | |
| Current Ratio | 9,83 | |
| Quick Ratio | 9,83 | |
| Equity Ratio | −0,69 | |
| Gross Profit Margin | - |
Rotate your device to see the full table